N-terminal brain natriuretic peptide in scleroderma-associated pulmonary arterial hypertension [5]

European Heart Journal

Volumn 28, Issue 1, 2007, Pages 140-141

  Mathai, Stephen C ^a   Hassoun, Paul M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

COMORBIDITY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEMODYNAMICS; HUMAN; LETTER; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCLERODERMA; STATISTICAL SIGNIFICANCE; SURVIVAL;

HUMANS; HYPERTENSION, PULMONARY; NATRIURETIC PEPTIDE, BRAIN; SCLERODERMA, SYSTEMIC;

EID: 33846347690     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl425     Document Type: Letter

References (7)

1. Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, and Coghlan JG. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 2006;27:1485-1494.
2. Mukerjee D, Yap LB, Holmes AM, Nair D, Ayrton P, Black CM, and Coghlan JG. Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension. Respir Med 2003;97:1230-1236.
3. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-982.
4. Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, Canham RM, Chung AK, Leonard D, Wians FH Jr, de Lemos JA. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 2005;112:2163-2168.
5. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, and Nielsen LB. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003;17:1105-1107.
6. McKie PM, Burnett JC Jr. B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities. Mayo Clin Proc 2005;80:1029-1036.
7. Girgis RE, Mathai SC, Champion HC, Hummers L, Wigley FM, and Hassoun PM. Determinants of survival in pulmonary hypertension associated with scleroderma. J Heart Lung Transplant 2006;25:S77.